טוען...
Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients
Dimethyl fumarate (DMF), a fumaric acid with antioxidant and immunomodulatory properties, is among the most commonly used oral therapies for relapsing multiple sclerosis. Progressive multifocal leukoencephalopathy (PML) has been associated with several disease-modifying therapies (DMT), including DM...
שמור ב:
| הוצא לאור ב: | Mult Scler |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7889744/ https://ncbi.nlm.nih.gov/pubmed/32808554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458520949158 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|